Cheryl S. Chang and Erika R. Schulz of Blank Rome.

Section 25704. Exposures to Listed Chemicals in Coffee Posing No Significant Risk

Exposures to listed chemicals in coffee created by and inherent in the processes of roasting coffee beans or brewing coffee do not pose a significant risk of cancer.

Background

The Litigation

Council for Education and Research on Toxics v. Starbucks

• The defendants' expert performed the wrong type of qualitative risk assessment, focusing on acrylamide instead of acrylamide in coffee, which was necessary to quantify the risk of cancer for this case.
• The method the defendants used to test for acrylamide was a novel scientific technique that had not been generally accepted in the scientific community, rendering it unreliable and inadmissible.
• A second expert provided rationales for an ASRL that the court deemed to be inadequate, lacking scientific support, and not based on sound considerations of public health.
• The defendants' evidence that coffee confers some benefit to human health was not persuasive and was refuted by the plaintiff's evidence.

Litigants' Response and Plaintiff's Challenge to Proposed Regulation

Conclusion

CERT CERT Cheryl S. Chang is a partner in Blank Rome's Los Angeles office who focuses her multifaceted practice on consumer class action defense, consumer financial services, and corporate litigation.

Erika R. Schulz is an associate in the firm's Los Angeles office who concentrates her practice on complex commercial litigation, class action suits, and unfair business practices.